Tarsus Pharmaceuticals In...

51.60
2.68 (5.48%)
At close: Apr 02, 2025, 3:59 PM
48.78
-5.46%
After-hours: Apr 02, 2025, 07:55 PM EDT

Tarsus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net Income -115.55M -135.89M -62.09M -13.83M -26.81M -4.67M -1.32M
Depreciation & Amortization 1.23M 877K 325K 312K 96K 37K 1K
Stock-Based Compensation 27.82M 19.83M 13.46M 8.46M 839K 18K 9K
Other Working Capital -4.31M 4.3M -1.77M -2.51M -1.78M 240K -5K
Other Non-Cash Items -360K -2.61M 227K 5.79M 3.27M 126K -116K
Deferred Income Tax n/a n/a n/a 1.65M 15K 331K n/a
Change in Working Capital 3.84M 306K -951K 1.37M 1.46M 485K 126K
Operating Cash Flow -83.03M -117.49M -49.03M 3.75M -21.14M -3.67M -1.18M
Capital Expenditures -1.57M -1.5M -506K -586K -456K -175K -7K
Acquisitions n/a n/a 144.12M n/a n/a n/a n/a
Purchase of Investments -265.63M -28.66M -149.44M n/a n/a n/a n/a
Sales Maturities Of Investments 73M 174.77M 5.32M n/a n/a n/a n/a
Other Investing Acitivies -5M -4M -144.12M n/a n/a n/a n/a
Investing Cash Flow -199.19M 140.6M -144.63M -586K -456K -175K -7K
Debt Repayment 75M 10M 20M n/a n/a 1.99M n/a
Common Stock Repurchased n/a n/a n/a n/a -28K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -18.63M 1.58M -365K 21K 370K n/a n/a
Financial Cash Flow 154.66M 130.18M 93.99M 21K 131.77M 59.45M 3.56M
Net Cash Flow -127.57M 153.29M -99.67M 3.18M 110.18M 55.6M 2.37M
Free Cash Flow -84.59M -123M -49.54M 3.16M -21.59M -3.85M -1.19M